相似文献
1
ATT- A Double Edged Sword?
Indian J Pharm Sci. 2011 Nov;73(6):663-5. doi: 10.4103/0250-474X.100241.
2
Live donor liver transplantation for antitubercular drug-induced acute liver failure.
Indian J Gastroenterol. 2017 Jan;36(1):56-61. doi: 10.1007/s12664-016-0725-1. Epub 2017 Jan 9.
3
Risk factors of acute hepatic failure during antituberculosis treatment: two cases and literature review.
Neth J Med. 2006 Nov;64(10):377-84.
4
Antioxidant status and GST gene polymorphisms in antitubercular treatment-induced hepatotoxicity patients.
Hepatol Int. 2013 Jul;7(3):876-82. doi: 10.1007/s12072-013-9452-1. Epub 2013 Jul 18.
5
Evaluation of Risk Factors for Development of Anti-Tubercular Therapy Induced Hepatotoxicity: A Prospective Study.
Curr Drug Saf. 2020;15(3):198-204. doi: 10.2174/1574886315666200626164554.
6
Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.
Liver Transpl. 2010 Oct;16(10):1136-46. doi: 10.1002/lt.22125.
7
Hepatotoxicity due to antituberculosis therapy. Clinical profile and reintroduction of therapy.
J Clin Gastroenterol. 1996 Apr;22(3):211-4. doi: 10.1097/00004836-199604000-00012.
8
Antitubercular therapy induced liver function tests abnormalities in human immunodeficiency virus infected individuals.
Med J Armed Forces India. 2017 Jan;73(1):12-17. doi: 10.1016/j.mjafi.2016.12.003. Epub 2017 Jan 7.
9
Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome.
Hepatology. 2010 May;51(5):1665-74. doi: 10.1002/hep.23534.
10
Antitubercular activity of garlic (allium sativum) extract on combination with conventional antitubercular drugs in tubercular lymphadenitis.
Indian J Clin Biochem. 1999 Jan;14(1):12-8. doi: 10.1007/BF02869146.
本文引用的文献
1
Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):182-9. doi: 10.1097/MPG.0b013e31821d6cfd.
2
Frequency of anti-tuberculous therapy-induced hepatotoxicity in patients and their outcome.
J Ayub Med Coll Abbottabad. 2009 Oct-Dec;21(4):50-2.
3
Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction.
Indian J Exp Biol. 2010 Mar;48(3):318-22.
4
Rifampicin-isoniazid induced fatal fulminant hepatitis during treatment of latent tuberculosis: A case report and literature review.
Indian J Crit Care Med. 2010 Apr;14(2):97-100. doi: 10.4103/0972-5229.68226.
5
Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome.
Hepatology. 2010 May;51(5):1665-74. doi: 10.1002/hep.23534.
6
Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
Clin Infect Dis. 2010 Mar 15;50(6):833-9. doi: 10.1086/650576.
7
[Study on liver damage caused by anti-TB drug intermittent treatment on patients with HBV-TB co-infection].
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Mar;30(3):286-9.
8
Drug-induced liver injury: is it somehow foreseeable?
World J Gastroenterol. 2009 Jun 21;15(23):2817-33. doi: 10.3748/wjg.15.2817.
9
Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies.
BMC Public Health. 2008 Oct 21;8:365. doi: 10.1186/1471-2458-8-365.
10
Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.
World J Gastroenterol. 2008 Aug 14;14(30):4753-62. doi: 10.3748/wjg.14.4753.
Zotero 插件